Search results for "Science" in Articles / App Notes
Article
A Closer Look at Affinity Ligands
…nt, Commercial and Technical Operations, BioCina; and Parviz Shamlou, PhD, senior vice-president of Science & Technology, Abzena illuminate the newest innovations with affinity ligands and provide a …
Article
Bracing for a Future Wave of Advanced Therapies
About the author
Feliza Mirasol is the science editor for BioPharm International.
Article Details
BioPharm International
Volume 37, No. 2
February 2024
Pages: 7–9
Cit…
Article
PEPTalk Event
Attend our talk, powerpoint presentations, and panel discussions to learn the latest in protein science.
LEARN MORE >>
Article
Cytiva expanding US operations
Cytiva, a global life sciences leader, is investing in additional resins manufacturing operations outside of Sweden, for the first time in the company’s history, with the acquisition of a …
Article
Analytical Considerations for Successful Upstream Process Development with Spivey and Lane
In 2016, he moved to the drug product science and technology department at BMS.
Today we're talking with him about upstream processes, continuous manufacturing, and just in general how the indus…
Article
Enhancing Resins Addresses Purification Concerns
About the author
Feliza Mirasol is the science editor for BioPharm International.
Article Details
BioPharm International
Vol. 35, No. 1
January 2022
Pages: 26…
Article
Implementing Inline Conditioning to Advance Process Intensification
Our engineering, operations and science departments participated in the equipment design and test together with the Cytiva subject matter experts (SMEs). Our people were able to travel to Sweden for t…
Article
In silico Approaches towards Automated Biomanufacturing
As part of manufacturing science and technology (MSAT), mechanistic modeling can be used to support several activities in biopharmaceutical production, including process transfer activities, in silico…
Article
Cytiva and Pall Corporation Investing 1.5 Billion USD Over Two Years to Meet Growing Demand for Biotechnology Solutions
Click here to read more >>
An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher (NYSE: DHR) Corporation, will expand manufacturing capacity and services acros…
Article
See How Solis BioDyne Turned to Cytiva to Support Production Ramp-Up
Click here to read more>>
Solis BioDyne is one of the many life sciences companies that experienced a dramatic increase in demand for its solutions during the COVID-19 pandemic. In a collabora…